Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 26 - 50 of 1616 in total
PF-04217903 has been used in trials studying the treatment of Neoplasms.
Investigational
Matched Name: … PF-04217903
Matched Description: … PF-04217903 has been used in trials studying the treatment of Neoplasms. …
Pf 03382792 is under investigation in clinical trial NCT01045863 (To Evaluate Safety, Tolerability, Plasma Drug Levels And Other Biological Effects In Healthy Volunteers).
Investigational
Matched Name: … PF-03382792
Matched Description: … Pf 03382792 is under investigation in clinical trial NCT01045863 (To Evaluate Safety, Tolerability, Plasma …
PF-03814735 has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Name: … PF-03814735
Matched Description: … PF-03814735 has been used in trials studying the treatment of Solid Tumors. …
PF-06459988 is under investigation in clinical trial NCT02297425 (A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer).
Investigational
Matched Name: … PF-06459988
Matched Description: … PF-06459988 is under investigation in clinical trial NCT02297425 (A Study For Patients With EGFRm (Epidermal …
PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects).
Investigational
Matched Name: … PF-04620110
Matched Description: … PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110
PF-04634817 is under investigation in clinical trial NCT01140672 (A Multiple Dose Study To Determine Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects).
Investigational
Matched Name: … PF-04634817
Matched Description: … Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects). ... PF-04634817 is under investigation in clinical trial NCT01140672 (A Multiple Dose Study To Determine …
PF-06700841 is under investigation in clinical trial NCT03236493 (Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy Volunteers).
Investigational
Matched Name: … PF-06700841
Matched Description: … PF-06700841 in Japanese Healthy Volunteers). ... PF-06700841 is under investigation in clinical trial NCT03236493 (Safety and Pharmacokinetic Study of …
PF-05105679 is under investigation in clinical trial NCT01393652 (Single Dose, Dose Escalation Healthy Volunteers Study Of PF-05105679).
Investigational
Matched Name: … PF-05105679
Matched Description: … Volunteers Study Of PF-05105679). ... PF-05105679 is under investigation in clinical trial NCT01393652 (Single Dose, Dose Escalation Healthy …
PF-05212377 is under investigation in clinical trial NCT01712074 (Study Evaluating Thesafety and Efficacy of PF-05212377 or Placebo in Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms on Donepezil).
Investigational
Matched Name: … PF-05212377
Matched Description: … PF-05212377 is under investigation in clinical trial NCT01712074 (Study Evaluating Thesafety and Efficacy ... of PF-05212377 or Placebo in Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms …
Investigational
Matched Name: … IKT-001Pro
Matched Salts name: … IKT-001 Mesylate …
Experimental
Withdrawn
Matched Name: … BMN-046
EF-022 is a modified version of vitamin D binding protein macrophage activator, with potential antineoplastic and anti-angiogenic activities.
Investigational
Matched Synonyms: … EF 022
Matched Name: … EF-022
Matched Description: … EF-022 is a modified version of vitamin D binding protein macrophage activator, with potential antineoplastic …
MDX-018, also known as HuMax-Inflam, is a fully human antibody that is directed to IL-8 (interleukin-8) and may have potential application in oncology and inflammation. Trials will initially focus on studies to treat glioblastoma, a cancer of the central nervous system. Other possible indications include chronic obstructive pulmonary disease (COPD)...
Investigational
Matched Name: … MDX-018
Matched Description: … MDX-018, also known as HuMax-Inflam, is a fully human antibody that is directed to IL-8 (interleukin- …
Investigational
Matched Name: … SNS-032
AIT-034 is a distinct chemical analog of hypoxanthine and pyrollidone that has been demonstrated in animal studies to enhance memory and to reverse memory deficits in severely impaired animals that do not respond to Neotrofin. AIT-034 does not induce the production of NGF, and its mechanism of action is therefore...
Investigational
Matched Name: … AIT-034
Matched Description: … AIT-034 is a distinct chemical analog of hypoxanthine and pyrollidone that has been demonstrated in animal ... AIT-034 does not induce the production of NGF, and its mechanism of action is therefore believed to be ... There is some evidence that AIT-034 could complement Neotrofin as a treatment for Alzheimer's disease …
Experimental
Matched Name: … K-00546
MK0249 has been used in trials studying the treatment of Hypopnea Syndrome, Alzheimer's Disease, Paranoid Schizophrenia, Sleep Apnea, Obstructive, and Excessive Daytime Sleepiness, among others.
Investigational
Matched Name: … MK-0249
OSI-027 has been used in trials studying the treatment of Any Solid Tumor or Lymphoma.
Investigational
Matched Name: … OSI-027
Matched Description: … OSI-027 has been used in trials studying the treatment of Any Solid Tumor or Lymphoma. …
AKN-028 has been used in trials studying the treatment of Acute Myeloid Leukemia.
Investigational
Matched Name: … AKN-028
Matched Description: … AKN-028 has been used in trials studying the treatment of Acute Myeloid Leukemia. …
MGD-024 is an anti-CD123/anti-CD3 bispecific DART molecule.
Investigational
Matched Name: … MGD-024
Matched Description: … MGD-024 is an anti-CD123/anti-CD3 bispecific DART molecule. …
ENB-003 is a selective and potent inhibitor of the endothelin B receptor (ETBR) being investigated for cancer.
Investigational
Matched Synonyms: … ENB 003
Matched Name: … ENB-003
Matched Description: … ENB-003 is a selective and potent inhibitor of the endothelin B receptor (ETBR) being investigated for …
MK-0482 is a novel humanized IgG4 monoclonal antibody targeting the immunoglobulin-like transcript (ILT) 3.
Investigational
Matched Name: … MK-0482
Matched Description: … MK-0482 is a novel humanized IgG4 monoclonal antibody targeting the immunoglobulin-like transcript (ILT …
KF-0210 is a small molecule developed by Keythera Pharmaceuticals. It is being investigated for cancers.
Investigational
Matched Name: … KF-0210
Matched Description: … KF-0210 is a small molecule developed by Keythera Pharmaceuticals. …
Investigational
Matched Synonyms: … VK-0214
Matched Name: … VK-0214
Investigational
Matched Synonyms: … ALX-009
Matched Name: … ALX-009
Displaying drugs 26 - 50 of 1616 in total